SEC Form 4 · accession 0001171843-17-007396
Anika Therapeutics, Inc. · ANIK
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Richard Hague
Officer — Chief Commercial Officer
Period of report
Nov 30, 2017
Accepted (ET)
Dec 1, 2017 · 4:05 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000898437
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 30, 2017 | S | 5,250 | $54.48 | D | 23,650 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 30, 2017, Mr. Hague sold 5,250 shares in multiple trades ranging from $54.20 to $54.98. The price reported above reflects the weighted average sale price. Mr. Hague undertakes to provide the Securities and Exchange Commission staff, the issuer or any security holder of the issuer, upon request, full information regarding the number of shares and prices at which the transactions were effected.